I 

114TH CONGRESS 

1ST SESSION H. R. 3092 

To provide for the issuance of an Alzheimer’s Disease Research Semipostal 

Stamp. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 16, 2015 

Ms. MAXINE WATERS of California (for herself, Mr. SMITH of New Jersey, 

Mr. FATTAH, Mr. GARAMENDI, Mrs. BEATTY, Mr. BRENDAN F. BOYLE

of Pennsylvania, Mr. BRADY of Pennsylvania, Ms. BROWN of Florida, Ms. 

CLARK of Massachusetts, Ms. CLARKE of New York, Mr. COHEN, Mr. 

CONNOLLY, Mr. DELANEY, Mrs. DINGELL, Mr. DOGGETT, Ms. 

EDWARDS, Ms. FRANKEL of Florida, Mr. GRIJALVA, Ms. HAHN, Mr. 

HASTINGS, Mr. HIGGINS, Mr. ISRAEL, Ms. JACKSON LEE, Mr. JOHNSON

of Georgia, Mr. KEATING, Ms. KELLY of Illinois, Mrs. LAWRENCE, Ms. 

LEE, Mr. LEWIS, Mr. LYNCH, Ms. MATSUI, Mr. MCGOVERN, Mr. NADLER, Ms. NORTON, Mr. PAYNE, Mr. POLIS, Mr. RANGEL, Ms. LINDA T. 

SA ́NCHEZ of California, Ms. LORETTA SANCHEZ of California, Ms. SCHAKOWSKY, Mr. DAVID SCOTT of Georgia, Mr. SIRES, Mr. TONKO, Mr. VAN

HOLLEN, Mrs. WATSON COLEMAN, Mr. LIPINSKI, and Mr. PETERS) introduced the following bill; which was referred to the Committee on Oversight and Government Reform, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the 

Speaker, in each case for consideration of such provisions as fall within 

the jurisdiction of the committee concerned 

A BILL 

To provide for the issuance of an Alzheimer’s Disease 

Research Semipostal Stamp. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


smartinez on DSK4TPTVN1PROD with BILLS
2 

•HR 3092 IH

1 SECTION 1. ALZHEIMER’S DISEASE RESEARCH SEMIPOST2 AL STAMP. 

3 (a) IN GENERAL.—In order to afford a convenient 

4 way for members of the public to contribute to funding 

5 for medical research relating to Alzheimer’s disease, the 

6 United States Postal Service shall issue a semipostal 

7 stamp (referred to in this Act as the ‘‘Alzheimer’s Disease 

8 Research Semipostal Stamp’’) in accordance with the pro9 visions of this section. 

10 (b) TERMS AND CONDITIONS.— 

11 (1) IN GENERAL.—The issuance and sale of the 

12 Alzheimer’s Disease Research Semipostal Stamp 

13 shall be governed by the provisions of section 416 of 

14 title 39, United States Code, and regulations issued 

15 under such section, subject to the requirements of 

16 this subsection. 

17 (2) DURATION.—The Alzheimer’s Disease Re18 search Semipostal Stamp shall be made available to 

19 the public for a period of 6 years, beginning no later 

20 than 12 months after the date of the enactment of 

21 this Act. 

22 (3) DISPOSITION OF PROCEEDS.—All amounts 

23 becoming available from the sale of the Alzheimer’s 

24 Disease Research Semipostal Stamp (as determined 

25 under section 416(d) of such title 39) shall be trans26 ferred to the National Institutes of Health, for the 


smartinez on DSK4TPTVN1PROD with BILLS
3 

•HR 3092 IH

1 purpose described in subsection (a), through pay2 ments which shall be made at least twice a year. 

3 (c) DEFINITION.—For purposes of this Act, the term 

4 ‘‘semipostal stamp’’ refers to a stamp described in section 

5 416(a)(1) of title 39, United States Code. 

Æ 


smartinez on DSK4TPTVN1PROD with BILLS